ProShares UltraShort NASDAQ Biotechnology
11 hedge funds and large institutions have $5.61M invested in ProShares UltraShort NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $6.05M → $5.61M (-$435K)
Holders
11
Holding in Top 10
1
Calls
$214K
Puts
–
Top Buyers
| 1 | +$520K | |
| 2 | +$310K | |
| 3 | +$156K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$134K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$38K |